Prasad R S, Vijayan E
School of Life Sciences, University of Hyderabad, India.
Contraception. 1987 Nov;36(5):567-80. doi: 10.1016/0010-7824(87)90009-6.
Effects of DL-204, 2-(3-ethoxyphenyl)-5,6-dihydro (5,1-a)-isoquinoline, a non-hormonal antifertility drug on testicular hyaluronidase and gamma-glutamyl transpeptidase levels, biochemical markers for testicular function, were evaluated in male rats. Treatment of 21-day-old rats with DL-204 for 7 or 15 days produced cryptorchid condition. Testicular hyaluronidase and gamma-glutamyl transpeptidase levels reveal that DL-204 acts on the testes, possibly in two ways; one, by reducing the gonadotropin levels thereby reducing the levels of androgens as reflected by reduced accessory reproductive organ weights and, secondly, by a direct action on the testes. Thus, we conclude that DL-204 is acting as an antispermatogenic agent, possibly acting in more than one way on the testes.
在雄性大鼠中评估了非激素抗生育药物DL-204(2-(3-乙氧基苯基)-5,6-二氢(5,1-a)-异喹啉)对睾丸透明质酸酶和γ-谷氨酰转肽酶水平(睾丸功能的生化标志物)的影响。用DL-204处理21日龄大鼠7天或15天会导致隐睾症。睾丸透明质酸酶和γ-谷氨酰转肽酶水平表明,DL-204可能通过两种方式作用于睾丸;其一,通过降低促性腺激素水平,从而降低雄激素水平,这可通过附属生殖器官重量减轻反映出来;其二,通过对睾丸的直接作用。因此,我们得出结论,DL-204作为一种抗生精剂,可能以多种方式作用于睾丸。